So I went and listed the tests that were approved by the TGA that either passed or failed scrutinisation in Germany from this list.
https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2021.26.44.2100441
This is real-world data from September 2020 to April 2021.
Anything <100% for Cq<25 is unacceptable. Of all those tests, Abbott's Panbio is the best, but it fails in the Cq>25 <30 department, making it not very useful.
How in the world did the TGA approve this rubbish and why is it still in the market? Based on that it's impossible for us to not get approval.
The competition, page-61
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $67.22M | |||
| Open | High | Low | Value | Volume |
| 2.7¢ | 2.9¢ | 2.7¢ | $17.68K | 634.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 541015 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 4693635 | 4 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| ADO (ASX) Chart |